McIlrath & Eck »

SPDR S&P Pharmaceuticals shares owned by McIlrath & Eck

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by McIlrath & Eck from 13F filings

Historical chart of McIlrath & Eck investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by McIlrath & Eck consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by McIlrath & Eck

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.3k 30 43.00

More positions owned by McIlrath & Eck

Vanguard Index Fds Rowth Etf (VUG)
Ea Series Trust Trive Total Ret (STXT)
Vanguard Index Fds Alue Etf (VTV)
Dimensional Etf Trust Ntl Core Eqt Mk (DFAI)
American Centy Etf Tr Vantis Us Mid C (AVMC)
Vanguard Index Fds Arge Cap Etf (VV)
Dimensional Etf Trust Hort Duration F (DFSD)
Fidelity Covington Trust Igh Divid Etf (FDVV)
Ea Series Trust Trive Enhanced (BUXX)
Ea Series Trust Trive Emerging (STXE)
Vanguard Index Fds Id Cap Etf (VO)
Capital Grp Fixed Incm Etf T Hort Duration (CGSD)
Vanguard Whitehall Fds M Mk Gov Bd Etf (VWOB)
Invesco Exch Traded Fd Tr Ii &p Intl Momnt (IDMO)
Schwab Strategic Tr Ntl Eqty Etf (SCHF)

View all positions for McIlrath & Eck

Top funds holding SPDR S&P Pharmaceuticals

Morgan Stanley
Envestnet Asset Management
LPL Financial
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Wells Fargo & Company
Cetera Investment Advisers
Jpmorgan Chase & Co
CX Institutional
Wharton Business Group
Clark Capital Management Group
Bp Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding SPDR S&P Pharmaceuticals